Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 057452/0831 | |
| Pages: | 6 |
| | Recorded: | 09/10/2021 | | |
| Attorney Dkt #: | C4019.10001US06 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17472128
|
Filing Dt:
|
09/10/2021
|
|
Publication #:
|
|
Pub Dt:
|
10/27/2022
| | | | |
|
Title:
|
DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION
|
|
|
Assignee
|
|
|
|
|
| 6465 SUNSET DRIVE |
| MIAMI, FLORIDA 33143 |
|
|
Correspondence name and address
|
| |
MASCHOFF BRENNAN
|
| |
1389 CENTER DRIVE, SUITE 300
|
| |
PARK CITY, UT 84098
|
Search Results as of:
05/25/2024 08:46 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
